Comparative analysis of 2 approaches to monitor countries' progress towards full and equal access to sexual and reproductive health care, information, and education in 75 countries: An observational validation study.

IF 15.8 1区 医学 Q1 Medicine PLoS Medicine Pub Date : 2024-12-31 eCollection Date: 2024-12-01 DOI:10.1371/journal.pmed.1004476
Jewel Gausman, Richard Adanu, Delia A B Bandoh, Neena R Kapoor, Ernest Kenu, Ana Langer, Magdalene A Odikro, Thomas Pullum, R Rima Jolivet
{"title":"Comparative analysis of 2 approaches to monitor countries' progress towards full and equal access to sexual and reproductive health care, information, and education in 75 countries: An observational validation study.","authors":"Jewel Gausman, Richard Adanu, Delia A B Bandoh, Neena R Kapoor, Ernest Kenu, Ana Langer, Magdalene A Odikro, Thomas Pullum, R Rima Jolivet","doi":"10.1371/journal.pmed.1004476","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Sustainable Development Goal (SDG) Indicator 5.6.2 is the \"Number of countries with laws and regulations that guarantee full and equal access to women and men aged 15 years and older to sexual and reproductive health care, information, and education.\" This indicator plays a key role in tracking global progress toward achieving gender equity and empowerment, ensuring its validity is essential. Significant challenges related to the indicator's calculation have been noted, which have important implications for the indicator's validity in measuring progress towards meeting the SDG target. Recommendations have been made to revise the scoring of the indicator. This study examines the indicator's validity by proposing a revision to the indicator's calculation that addresses these global concerns and comparing the resulting values.</p><p><strong>Methods and findings: </strong>This is an observational, validation study which used secondary data from the 2022 United Nations Population Fund's Sexual and Reproductive Health and Rights Country Profiles from 75 countries. To address global recommendations, we proposed making 2 changes to the indicator's calculation. First, we re-expressed all barriers and enablers to take positive values. Second, we used a weighted additive approach to calculate the total score, rather than the mean of the 13 individual component scores, which assigns equal weight to the substantive domains rather than the components. Our main outcome measures are the indicator values obtained from both scoring approaches examined. We assessed the indicator's convergent validity by comparing the value obtained using the indicator's current formula to the proposed formula using the Bland-Altman approach. We examined and interpreted changes in the indicator's overall score that result from comparing the existing indicator with the proposed alternative. Differences in the total value of the indicator comparing the alternative versus the current formulation range from -7.18 percentage points in Mali to 26.21 percentage points in South Sudan. The majority of countries (n = 47) had an increase in total indicator score as a result of the alternative formula, while 27 countries had a decrease in score. Only 1 country, Sweden, saw no change in score, as it scored 100% of the possible indicator value under both rubrics. The mean difference between the scores produced by the 2 measures is 2.28 suggesting that the 2 methods may produce systematically different results. Under the alternative formulation, the most substantial changes were observed in the scores for \"Component 3: Abortion.\" The indicator's current calculation results in 16 countries being assigned a score of zero, for \"Component 3: Abortion\" which masks important differences in the number of legal barriers present and whether women can be criminally charged for illegal abortion. After re-expressing barriers on a positive scale following the proposed formulation, only 4 countries have a score of zero for Component 3. The main limitation of our methodology is that there is no gold standard for measurement of the phenomenon under study, and thus we are unable to specify with total certainty which indicator performs better.</p><p><strong>Conclusions: </strong>Our results illustrate underlying challenges with the current indicator formulation that impact its interpretability. The proposed changes could alter the way the current legal landscape governing sexual and reproductive health is understood, thereby pointing to different programmatic and policy priorities that may better support countries in achieving full and equal access to sexual and reproductive health and rights globally.</p>","PeriodicalId":49008,"journal":{"name":"PLoS Medicine","volume":"21 12","pages":"e1004476"},"PeriodicalIF":15.8000,"publicationDate":"2024-12-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11687741/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"PLoS Medicine","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1371/journal.pmed.1004476","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/12/1 0:00:00","PubModel":"eCollection","JCR":"Q1","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Sustainable Development Goal (SDG) Indicator 5.6.2 is the "Number of countries with laws and regulations that guarantee full and equal access to women and men aged 15 years and older to sexual and reproductive health care, information, and education." This indicator plays a key role in tracking global progress toward achieving gender equity and empowerment, ensuring its validity is essential. Significant challenges related to the indicator's calculation have been noted, which have important implications for the indicator's validity in measuring progress towards meeting the SDG target. Recommendations have been made to revise the scoring of the indicator. This study examines the indicator's validity by proposing a revision to the indicator's calculation that addresses these global concerns and comparing the resulting values.

Methods and findings: This is an observational, validation study which used secondary data from the 2022 United Nations Population Fund's Sexual and Reproductive Health and Rights Country Profiles from 75 countries. To address global recommendations, we proposed making 2 changes to the indicator's calculation. First, we re-expressed all barriers and enablers to take positive values. Second, we used a weighted additive approach to calculate the total score, rather than the mean of the 13 individual component scores, which assigns equal weight to the substantive domains rather than the components. Our main outcome measures are the indicator values obtained from both scoring approaches examined. We assessed the indicator's convergent validity by comparing the value obtained using the indicator's current formula to the proposed formula using the Bland-Altman approach. We examined and interpreted changes in the indicator's overall score that result from comparing the existing indicator with the proposed alternative. Differences in the total value of the indicator comparing the alternative versus the current formulation range from -7.18 percentage points in Mali to 26.21 percentage points in South Sudan. The majority of countries (n = 47) had an increase in total indicator score as a result of the alternative formula, while 27 countries had a decrease in score. Only 1 country, Sweden, saw no change in score, as it scored 100% of the possible indicator value under both rubrics. The mean difference between the scores produced by the 2 measures is 2.28 suggesting that the 2 methods may produce systematically different results. Under the alternative formulation, the most substantial changes were observed in the scores for "Component 3: Abortion." The indicator's current calculation results in 16 countries being assigned a score of zero, for "Component 3: Abortion" which masks important differences in the number of legal barriers present and whether women can be criminally charged for illegal abortion. After re-expressing barriers on a positive scale following the proposed formulation, only 4 countries have a score of zero for Component 3. The main limitation of our methodology is that there is no gold standard for measurement of the phenomenon under study, and thus we are unable to specify with total certainty which indicator performs better.

Conclusions: Our results illustrate underlying challenges with the current indicator formulation that impact its interpretability. The proposed changes could alter the way the current legal landscape governing sexual and reproductive health is understood, thereby pointing to different programmatic and policy priorities that may better support countries in achieving full and equal access to sexual and reproductive health and rights globally.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
监测各国在75个国家全面和平等地获得性健康和生殖卫生保健、信息和教育方面进展的两种方法的比较分析:一项观察性验证研究。
背景:可持续发展目标指标5.6.2是“制定法律法规保障15岁及以上男女充分和平等地获得性健康和生殖健康保健、信息和教育的国家数量”。这一指标在跟踪全球在实现性别平等和赋权方面的进展方面发挥着关键作用,确保其有效性至关重要。已注意到与该指标计算有关的重大挑战,这对该指标在衡量实现可持续发展目标进展情况方面的有效性具有重要影响。已提出建议修订该指标的评分。本研究通过提出对指标计算的修正来检验指标的有效性,该修正解决了这些全球关注的问题,并比较了结果值。方法和发现:这是一项观察性验证研究,使用了来自75个国家的2022年联合国人口基金性健康和生殖健康及权利国家概况的二手数据。为了应对全球的建议,我们建议对该指标的计算方法进行两项修改。首先,我们重新表达了所有的障碍和推动因素,以采取积极的价值观。其次,我们使用加权加法方法来计算总分,而不是13个单独成分得分的平均值,这将同等的权重分配给实质性领域,而不是成分。我们的主要结果测量是从两种评分方法中获得的指标值。我们通过比较使用指标当前公式获得的值与使用Bland-Altman方法提出的公式来评估指标的收敛效度。我们检查并解释了通过比较现有指标和提议的替代方案而产生的指标总分的变化。将替代方案与现行方案进行比较,该指标的总价值差异从马里的-7.18个百分点到南苏丹的26.21个百分点不等。大多数国家(n = 47)的总指标得分由于替代公式而增加,而27个国家的得分下降。只有瑞典一个国家的得分没有变化,因为它在两个指标下都获得了100%的可能指标值。两种方法产生的分数之间的平均差异为2.28,这表明两种方法可能产生系统不同的结果。在另一种形式下,最实质性的变化是在“成分3:堕胎”的得分中观察到的。该指标目前的计算结果显示,16个国家的“组成部分3:堕胎”得分为零,这掩盖了存在的法律障碍数量和妇女是否可以因非法堕胎受到刑事指控的重要差异。在按照提议的提法以积极的尺度重新表述障碍之后,只有4个国家在构成部分3的得分为零。我们的方法的主要限制是,没有金标准来测量所研究的现象,因此我们无法完全确定哪个指标表现更好。结论:我们的研究结果说明了影响其可解释性的当前指标制定的潜在挑战。拟议的修改可能改变人们对目前管理性健康和生殖健康的法律格局的理解方式,从而指出不同的方案和政策优先事项,这些优先事项可能更好地支持各国在全球实现充分和平等地享有性健康和生殖健康及权利。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
PLoS Medicine
PLoS Medicine MEDICINE, GENERAL & INTERNAL-
CiteScore
17.60
自引率
0.60%
发文量
227
审稿时长
4-8 weeks
期刊介绍: PLOS Medicine is a prominent platform for discussing and researching global health challenges. The journal covers a wide range of topics, including biomedical, environmental, social, and political factors affecting health. It prioritizes articles that contribute to clinical practice, health policy, or a better understanding of pathophysiology, ultimately aiming to improve health outcomes across different settings. The journal is unwavering in its commitment to uphold the highest ethical standards in medical publishing. This includes actively managing and disclosing any conflicts of interest related to reporting, reviewing, and publishing. PLOS Medicine promotes transparency in the entire review and publication process. The journal also encourages data sharing and encourages the reuse of published work. Additionally, authors retain copyright for their work, and the publication is made accessible through Open Access with no restrictions on availability and dissemination. PLOS Medicine takes measures to avoid conflicts of interest associated with advertising drugs and medical devices or engaging in the exclusive sale of reprints.
期刊最新文献
Consecutive prediction of adverse maternal outcomes of preeclampsia, using the PIERS-ML and fullPIERS models: A multicountry prospective observational study. Effects of X-ray-based diagnosis and explanation of knee osteoarthritis on patient beliefs about osteoarthritis management: A randomised clinical trial. Impact evaluation of a digital health platform empowering Kenyan women across the pregnancy-postpartum care continuum: A cluster randomized controlled trial. Risk of placenta previa in assisted reproductive technology: A Nordic population study with sibling analyses. The effect of prenatal balanced energy and protein supplementation on gestational weight gain: An individual participant data meta-analysis in low- and middle-income countries.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1